MedPath

Effect of Candesarutan and Piogritazon in diabetic patients with hypertensio

Not Applicable
Conditions
Diabetic patients with hypertension
Registration Number
JPRN-UMIN000010142
Lead Sponsor
The jikei University School of Medicin
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

Contraindicated of Piogritazon and Candesartan. Informed consent can not be obtained. Patients judged to be unsuitable

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluation of marker for inflammation in diabetic patients with hypertension
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath